Tag Archives: THC BioMed

THC BioMed

THC Announces $10,000,000 Capital Commitment

THC Announces $10,000,000 Capital Commitment

VANCOUVER, British Columbia, March 16, 2017 /Weed Wire/ — THC BioMed Intl Ltd. (“THC” or the “Company”) (CSE:THC) announces that it has entered into a capital commitment agreement (the “Capital Commitment”) with GEM Global Yield Fund LLC SCS (“GEM”) for a $10 million Capital Commitment from GEM to invest into THC.

THC BioMed

Health Canada Issues THC BioMed amendment to Sell Starting Materials and Grants THC Permission to Conduct In-House Analytical Testing – THC to Expand its Facilities

VANCOUVER, British Columbia, Dec. 20, 2016 /Weed Wire/ — THC BioMed Intl Ltd. (“THC” or the “Company”) (CSE: THC) (CSE: THC.CN) (CNSX: THC) (OTCQB: THCBF) (FRANKFURT: TFHC) is pleased to announce several new developments relating to its new, amended license from Health Canada, the launch of its revamped website, the expansion of its facilities and changes in its work with Supra Research and Development Inc. (“Supra”).

THC BioMed

High demand for Clone Shipper; THC Enters into Exclusive Distribution Agreement with Clone Shipper

VANCOUVER, British Columbia, Nov. 1, 2016 /Weed Wire/ — THC BioMed Intl Ltd. (“THC” or the “Company”) (CSE: THC) (CSE: THC.CN) (CNSX: THC) (OTC PINK: THCBF) (FRANKFURT: TFHC) is pleased to announce that due to the high demand for Clone Shipper products, THC has entered into an exclusive agreement with Clone Shipper for the distribution rights for all of Canada.

THC BioMed

THC BioMed Receives License Amendment

VANCOUVER, British Columbia, Oct. 18,2016 /Weed Wire/ — THC BioMed Ltd. (CSE: THC) (OTC PINK: THCBF) (FRANKFURT: TFHC) (“THC” or the “Company”) is pleased to report that it has had its license amended by Health Canada and will begin to initiate its business plan by inter-trading between licensed producers to strengthen its products and service.

THC BioMed

Health Canada Grants THC BioMed Oil Production License

THC BioMed Successfully Imports 28 Dutch Cannabis Strains   VANCOUVER, British Columbia, May 24, 2016 /Weed Wire/ — THC BioMed Intl. Ltd. (CSE: THC) (OTC PINK: THCBF) (FRANKFURT: TFHC) is pleased to announce that our wholly-owned subsidiary, THC BioMed Ltd. has been granted authorization by Health Canada to produce fresh marijuana, Cannabis Oil and Cannabis Resin. This license allows us

THC BioMed

Health Canada Grants THC BioMed Licence to Cultivate Marihuana

VANCOUVER, British Columbia, Feb. 22, 2016 /Weed Wire/ — THC BioMed Intl. Ltd. (CSE:THC) (OTC PINK:THCBF) (FRANKFURT:TFHC) is pleased to announce that our wholly-owned subsidiary, THC BioMed Ltd. has been granted a license to produce medical marihuana under Health Canada’s Marihuana for Medical Purposes Regulations (MMPR).


Top